CORALVILLE, Iowa, Nov. 29, 2015 /PRNewswire/ -- CIVCO Medical
Solutions will demonstrate the latest in ultrasound guidance
technology at the Radiological Society of North America annual conference in
Chicago November 29 – December 4,
2015. The Verza needle guidance system is designed to offer
customers unrivaled versatility, enhanced user experience and
deliver confident clinical outcomes.
Photo - http://photos.prnewswire.com/prnh/20151125/291134
"Verza was developed with input from leading clinicians around
the world, with a goal to make ultrasound guided interventions
simpler, and to expand the clinical utility of ultrasound guidance
systems", said Julie Meyer, CIVCO
director of clinical marketing. "We believe that Verza, in
combination with leading ultrasound equipment, will significantly
enhance clinician experience using guides."
A key feature of the Verza system is its direct transducer
attachment, in combination with
VerzaLink™, a proprietary locating
feature designed into the ultrasound transducer, eliminating the
need for a custom bracket attachment, and providing an ideal
profile and position on the ultrasound probe. Additionally,
VerzaLink removes time and costs associated with bracket set-up,
cleaning, storage and maintenance.
The Verza system was developed to meet the needs of clinicians
accustomed to fixed-angle guidance as well as those who prefer a
free-hand technique. Offering a selection of five potential
approach angles, the Verza guide provides an optimal pathway for a
wide assortment of anatomical targets, and, with 14 instrument
inserts, ranging in size from 25 gauge to 12 French, Verza is
designed for compatibility with the market's largest range of
interventional devices.
Building on the improvements of previous CIVCO offerings such as
Infiniti Plus™ and the Ultra
Pro™ family of products, Verza delivers improved
flexibility, optimal stability, increased accuracy and more
efficient functionality while minimizing blind zone and unguided
needle length. All of this provides the benefits of decreased
procedure time and fewer complications that result from poor needle
visibility.
Verza is pending US FDA 510(k) clearance. International patents
are pending. Verza is planned for launch with leading ultrasound
equipment in 2016.
Visit WWW.CIVCO.COM to learn more.
CIVCO will showcase Verza at the Radiological Society of
North America (RSNA) Annual
Meeting in Chicago Nov. 29–Dec. 4,
2015. Visit CIVCO at South, Hall A, Booth 2317 to experience Verza.
Additional show information is available at
www.rsna.org.
About CIVCO
CIVCO Medical Solutions has over 30 years
of experience and offers cutting-edge medical technology to a
diverse group of medical professionals. The Multi-Modality Imaging
(MMI) unit designs and manufactures accessories for use in
diagnostic and therapeutic imaging and interventional procedures
with a strong focus on ultrasound. MMI's products range from
infection control products including a wide range of ultrasound and
CT covers to device guidance, positioning and electromagnetic
needle tracking, CIVCO offers patients and clinicians the newest
and best technology available to improve patient care. Corporate
information is available at WWW.CIVCO.COM.
For more information or product images, please
contact:
Shannon Webb
CIVCO Medical Solutions
Tel: 319.248.6569
shannon.webb@civco.com
COPYRIGHT © 2015. CIVCO IS A REGISTERED TRADEMARK
OF CIVCO MEDICAL SOLUTIONS. VERZA, VERZALINK, INFINITI PLUS, AND
ULTRA-PRO ARE TRADEMARKS OF CIVCO. ALL PRODUCTS MAY NOT BE LICENSED
IN ACCORDANCE WITH CANADIAN LAW. 2015C-2886 REV 1
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/civco-to-demonstrate-next-generation-ultrasound-guide-at-rsna-300184706.html
SOURCE CIVCO Medical Solutions